Cargando…
Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) is a member of the spindle assembly checkpoint protein family, which has been proven to be associated with many kinds of cancers. The aim of this study was to investigate whether BUB1B was correlated with progression and prognosis in patients...
Autores principales: | Fu, Xin, Chen, Guo, Cai, Zhi-duan, Wang, Cong, Liu, Ze-zhen, Lin, Zhuo-yuan, Wu, Yong-ding, Liang, Yu-xiang, Han, Zhao-dong, Liu, Jun-chen, Zhong, Wei-De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844448/ https://www.ncbi.nlm.nih.gov/pubmed/27143916 http://dx.doi.org/10.2147/OTT.S101994 |
Ejemplares similares
-
Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer
por: Zeng, Yan-Ru, et al.
Publicado: (2015) -
Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
por: Chen, Chaojiang, et al.
Publicado: (2020) -
Overexpression of TPX2 is associated with progression and prognosis of prostate cancer
por: Zou, Jun, et al.
Publicado: (2018) -
Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014) -
Aberrant Expression of BUB1B Contributes to the Progression of Thyroid Carcinoma and Predicts Poor Outcomes for Patients
por: Yan, Hai-chao, et al.
Publicado: (2022)